Valuation: Mega Lifesciences

Market Cap 28.55B 847M 759M 700M 633M 1.18B 80.66B 1.2B 8.35B 3.33B 42.21B 3.18B 3.11B 134B P/E 2026 *
12.5x
P/E 2027 * 11.5x
Enterprise Value 23.94B 710M 636M 587M 531M 993M 67.62B 1.01B 7B 2.79B 35.39B 2.66B 2.61B 112B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.54x
Free-Float
38.66%
Yield 2026 *
5.44%
Yield 2027 * 5.83%
1 day-3.68%
1 week-5.07%
Current month-2.96%
1 month-5.07%
3 months-12.67%
6 months-7.09%
Current year-2.24%
1 week 32.5
Extreme 32.5
34.75
1 month 32.5
Extreme 32.5
34.75
Current year 31.5
Extreme 31.5
40
1 year 28.75
Extreme 28.75
40
3 years 24.3
Extreme 24.3
44.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 62 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-3.68%-5.07% - - 847M
+3.72%+12.40%+69.49%+153.02% 1,224B
+1.34%+6.60%+48.76%+91.28% 662B
+2.41%+3.47%+29.51%+108.29% 514B
+0.49%+3.30%+54.30%+67.34% 388B
+2.87%+4.03%+75.15%+47.18% 361B
+1.80%+5.28%+36.29%+59.23% 302B
+6.94%+8.28%+10.68%+35.90% 271B
+2.72%+7.92%+62.34%+80.12% 249B
+3.68%+11.67%+47.12%+124.06% 205B
Average +2.16%+2.59%+48.18%+85.16% 464.09B
Weighted average by Cap. +2.71%+3.04%+52.62%+100.46%

Financials

2026 *2027 *
Net sales 14.33B 425M 381M 351M 318M 594M 40.48B 604M 4.19B 1.67B 21.19B 1.6B 1.56B 67.1B 15.5B 460M 412M 380M 344M 643M 43.78B 653M 4.53B 1.81B 22.91B 1.73B 1.69B 72.57B
Net income 2.24B 66.53M 59.6M 54.98M 49.75M 93.04M 6.34B 94.54M 656M 262M 3.32B 250M 244M 10.5B 2.49B 73.74M 66.05M 60.93M 55.14M 103M 7.02B 105M 727M 290M 3.68B 277M 271M 11.64B
Net Debt -4.62B -137M -123M -113M -102M -191M -13.04B -195M -1.35B -539M -6.83B -514M -503M -21.62B -4.72B -140M -125M -116M -105M -196M -13.33B -199M -1.38B -551M -6.98B -525M -514M -22.1B
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
29/10/26 THB 32.75 -3.68% 2,371,500
28/10/26 THB 34.00 0.00% 934,500
27/10/26 THB 34.00 -0.73% 2,093,700
26/10/26 THB 34.25 -0.72% 1,847,000
22/10/26 THB 34.50 +2.99% 710,200
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
32.75THB
Average target price
42.71THB
Spread / Average Target
+30.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences